Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Butler

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Journal of Medicinal Chemistry|April 4, 2018
Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking HypopigmentationBrian T O'Neill, Elizabeth M Beck, Christopher R Butler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 10, 2023
Neuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating ScalesKiran Samra, Amy Macdougall, Georgia Peakman, et al.
Journal of Neurology|December 20, 2022
Language impairment in the genetic forms of behavioural variant frontotemporal dementiaKiran Samra, Amy M MacDougall, Arabella Bouzigues, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 16, 2020
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementiaCarolin Heller, Martha S Foiani, Katrina Moore, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 5, 2022
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for <i>C9orf72</i>-associated frontotemporal dementia and amyotrophic lateral sclerosisKatherine M Wilson, Eszter Katona, Idoia Glaria, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 11, 2020
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementiaEmma L van der Ende, Meifang Xiao, Desheng Xu, et al.
Brain Communications|November 17, 2025
Thalamus involvement in genetic frontotemporal dementia assessed using structural and diffusion MRI: a GENFI studySonja Soskic, Henry F J Tregidgo, Emily G Todd, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cross-country variance in facial emotion recognition in presymptomatic and symptomatic behavioral variant frontotemporal dementia: Insights from the GENFI and ReDLat consortiaLiset de Boer, Lize C Jiskoot, Harro Seelaar, et al.
Brain : a Journal of Neurology|October 11, 2021
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementiaEmma L van der Ende, Esther E Bron, Jackie M Poos, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Journal of Medicinal Chemistry|April 4, 2018
Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking HypopigmentationBrian T O'Neill, Elizabeth M Beck, Christopher R Butler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 10, 2023
Neuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating ScalesKiran Samra, Amy Macdougall, Georgia Peakman, et al.
Journal of Neurology|December 20, 2022
Language impairment in the genetic forms of behavioural variant frontotemporal dementiaKiran Samra, Amy M MacDougall, Arabella Bouzigues, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 16, 2020
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementiaCarolin Heller, Martha S Foiani, Katrina Moore, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 5, 2022
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for <i>C9orf72</i>-associated frontotemporal dementia and amyotrophic lateral sclerosisKatherine M Wilson, Eszter Katona, Idoia Glaria, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 11, 2020
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementiaEmma L van der Ende, Meifang Xiao, Desheng Xu, et al.
Brain Communications|November 17, 2025
Thalamus involvement in genetic frontotemporal dementia assessed using structural and diffusion MRI: a GENFI studySonja Soskic, Henry F J Tregidgo, Emily G Todd, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cross-country variance in facial emotion recognition in presymptomatic and symptomatic behavioral variant frontotemporal dementia: Insights from the GENFI and ReDLat consortiaLiset de Boer, Lize C Jiskoot, Harro Seelaar, et al.
Brain : a Journal of Neurology|October 11, 2021
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementiaEmma L van der Ende, Esther E Bron, Jackie M Poos, et al.
Pageof 9